• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

-(4-氯苯基)取代的吡喃并[2,3-c]吡唑的合成及其对 PKBβ/AKT2 的抑制作用和抗神经胶质瘤活性。

Synthesis of -(4-chlorophenyl) substituted pyrano[2,3-c]pyrazoles enabling PKBβ/AKT2 inhibitory and anti-glioma activity.

机构信息

Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, India.

Department of Cellular & Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.

出版信息

Ann Med. 2022 Dec;54(1):2549-2561. doi: 10.1080/07853890.2022.2123559.

DOI:10.1080/07853890.2022.2123559
PMID:36120909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9683054/
Abstract

A series of -(4-chlorophenyl) substituted pyrano[2,3-c]pyrazoles was synthesised and screened for their potential to inhibit kinases and exhibit anticancer activity against primary patient-derived glioblastoma 2D cells and 3D neurospheres. A collection of 10 compounds was evaluated against glioma cell lines, with compound exhibiting promising glioma growth inhibitory properties. Compound was screened against 139 purified kinases and exhibited low micromolar activity against kinase AKT2/PKBβ. AKT signalling is one of the main oncogenic pathways in glioma and is often targeted for novel therapeutics. Indeed, AKT2 levels correlated with glioma malignancy and poorer patient survival. Compound inhibited the 3D neurosphere formation in primary patient-derived glioma stem cells and exhibited potent EC against glioblastoma cell lines. Although exhibiting potency against glioma cells, exhibited significantly less cytotoxicity against non-cancerous cells even at fourfold-fivefold the concentration. Herein we establish a novel biochemical kinase inhibitory function for -(4-chlorophenyl) substituted pyrano[2,3-c]pyrazoles and further report their anti-glioma activity for the first time.KEY MESSAGEAnti-glioma pyrano[2,3-c]pyrazole inhibited the 3D neurosphere formation in primary patient-derived glioma stem cells. also displayed PKBβ/AKT2 inhibitory activity. is nontoxic towards non-cancerous cells.

摘要

一系列 -(4-氯苯基)取代的吡喃并[2,3-c]吡唑被合成并筛选其抑制激酶的潜力,并对原代患者来源的胶质母细胞瘤 2D 细胞和 3D 神经球表现出抗癌活性。评价了 10 种化合物对神经胶质瘤细胞系的活性,其中化合物 表现出有希望的神经胶质瘤生长抑制特性。化合物 对 139 种纯化激酶进行了筛选,对激酶 AKT2/PKBβ 表现出低微摩尔活性。AKT 信号通路是神经胶质瘤的主要致癌途径之一,经常被用于新型治疗方法。事实上,AKT2 水平与神经胶质瘤的恶性程度和患者的生存预后相关。化合物 抑制原代患者来源的神经胶质瘤干细胞中的 3D 神经球形成,并对神经母细胞瘤细胞系表现出强大的 EC。尽管对神经胶质瘤细胞表现出活性,但化合物 对非癌细胞的细胞毒性明显较低,即使在四倍至五倍浓度下也是如此。本文建立了一种新型的 -(4-氯苯基)取代的吡喃并[2,3-c]吡唑的生化激酶抑制功能,并首次报道了其抗神经胶质瘤活性。

关键信息

抗神经胶质瘤吡喃并[2,3-c]吡唑 抑制原代患者来源的神经胶质瘤干细胞的 3D 神经球形成。 还显示出 PKBβ/AKT2 抑制活性。 对非癌细胞无毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/41be42214a2e/IANN_A_2123559_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/0f311a931302/IANN_A_2123559_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/3d735bc811df/IANN_A_2123559_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/cb0b4724bf38/IANN_A_2123559_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/d125b16bca64/IANN_A_2123559_SCH0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/ef9f4c91d741/IANN_A_2123559_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/10ec2f5c7420/IANN_A_2123559_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/41be42214a2e/IANN_A_2123559_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/0f311a931302/IANN_A_2123559_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/3d735bc811df/IANN_A_2123559_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/cb0b4724bf38/IANN_A_2123559_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/d125b16bca64/IANN_A_2123559_SCH0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/ef9f4c91d741/IANN_A_2123559_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/10ec2f5c7420/IANN_A_2123559_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/9683054/41be42214a2e/IANN_A_2123559_F0004_C.jpg

相似文献

1
Synthesis of -(4-chlorophenyl) substituted pyrano[2,3-c]pyrazoles enabling PKBβ/AKT2 inhibitory and anti-glioma activity.-(4-氯苯基)取代的吡喃并[2,3-c]吡唑的合成及其对 PKBβ/AKT2 的抑制作用和抗神经胶质瘤活性。
Ann Med. 2022 Dec;54(1):2549-2561. doi: 10.1080/07853890.2022.2123559.
2
Design and discovery of novel pyrazole-pyrrolopyrimidine derivatives as anti-glioma agents via promoting apoptosis, inhibiting cell cycle and EGFR-TK.通过促进细胞凋亡、抑制细胞周期和表皮生长因子受体酪氨酸激酶,设计并发现新型吡唑-吡咯并嘧啶衍生物作为抗胶质瘤药物。
Chem Biol Drug Des. 2023 Nov;102(5):1248-1256. doi: 10.1111/cbdd.14320. Epub 2023 Aug 28.
3
Synthesis and potential biological activity of some novel 3-[(N-substituted indol-3-yl)methyleneamino]-6-amino-4-aryl-pyrano(2,3-c)pyrazole-5-carbonitriles and 3,6-diamino-4-(N-substituted indol-3-yl)pyrano(2,3-c)pyrazole-5-carbonitriles.一些新型 3-[(N-取代吲哚-3-基)亚甲基氨基]-6-氨基-4-芳基-吡喃(2,3-c)吡唑-5-甲腈和 3,6-二氨基-4-(N-取代吲哚-3-基)吡喃(2,3-c)吡唑-5-甲腈的合成及潜在生物活性。
Acta Pharm. 2012 Mar;62(1):15-30. doi: 10.2478/v10007-012-0007-0.
4
Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function.肿瘤坏死因子样凋亡弱诱导物刺激神经胶质瘤细胞存活依赖于 Akt2 功能。
Mol Cancer Res. 2009 Nov;7(11):1871-81. doi: 10.1158/1541-7786.MCR-09-0194. Epub 2009 Oct 27.
5
Evaluation of Pyrano[3,2 C] Quinoline Analogues as Anticancer Agents.吡喃并[3,2-c]喹啉类似物作为抗癌剂的评价。
Anticancer Agents Med Chem. 2019;19(10):1285-1292. doi: 10.2174/1871520619666190308122734.
6
Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.四氧化四砷通过减少基质金属蛋白酶分泌和蛋白激酶B磷酸化来抑制恶性胶质瘤细胞的体外侵袭。
J Neurosurg. 2014 Dec;121(6):1483-91. doi: 10.3171/2014.8.JNS131991. Epub 2014 Oct 10.
7
Akt2 and Akt3 play a pivotal role in malignant gliomas.Akt2 和 Akt3 在恶性神经胶质瘤中起着关键作用。
Neuro Oncol. 2010 Mar;12(3):221-32. doi: 10.1093/neuonc/nop026. Epub 2009 Dec 21.
8
Reduction of Akt2 inhibits migration and invasion of glioma cells.Akt2的减少会抑制胶质瘤细胞的迁移和侵袭。
Int J Cancer. 2009 Aug 1;125(3):585-95. doi: 10.1002/ijc.24314.
9
Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.白藜芦醇靶向作用于胶质母细胞瘤和胶质母细胞瘤干细胞中的 AKT 和 p53 以抑制生长和浸润。
J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15.
10
Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides.含吡唑的二芳基脲和二芳基酰胺的合成、体外增殖活性及激酶抑制作用。
Eur J Med Chem. 2018 Aug 5;156:230-239. doi: 10.1016/j.ejmech.2018.07.008. Epub 2018 Jul 6.

引用本文的文献

1
Antimicrobial Efficacy of 1,2,3-Triazole-Incorporated Indole-Pyrazolone against Drug-Resistant ESKAPE Pathogens: Design and Synthesis.含1,2,3-三唑的吲哚-吡唑啉酮对耐药ESKAPE病原体的抗菌效力:设计与合成
ACS Bio Med Chem Au. 2025 Jan 28;5(1):66-77. doi: 10.1021/acsbiomedchemau.4c00060. eCollection 2025 Feb 19.
2
Recent highlights in the synthesis and biological significance of pyrazole derivatives.吡唑衍生物的合成及其生物学意义的近期研究要点
Heliyon. 2024 Oct 9;10(20):e38894. doi: 10.1016/j.heliyon.2024.e38894. eCollection 2024 Oct 30.
3
One-pot synthesis of tetrahydropyrimidinecarboxamides enabling anticancer activity: a combinative study with clinically relevant brain-penetrant drugs.

本文引用的文献

1
Synthesis, crystal structure and studies of novel 2,4-dimethoxy-tetrahydropyrimido[4,5-]quinolin-6(7)-ones.新型2,4 - 二甲氧基 - 四氢嘧啶并[4,5 - ]喹啉 - 6(7) - 酮的合成、晶体结构及研究
RSC Adv. 2022 Jun 29;12(29):18806-18820. doi: 10.1039/d2ra02694e. eCollection 2022 Jun 22.
2
Pyridine-2-carboxylic acid as an effectual catalyst for rapid multi-component synthesis of pyrazolo[3,4-]quinolinones.吡啶 -2- 羧酸作为快速多组分合成吡唑并[3,4-]喹啉酮的有效催化剂。
RSC Adv. 2020 Sep 25;10(58):35499-35504. doi: 10.1039/d0ra06738e. eCollection 2020 Sep 21.
3
A novel substrate directed multicomponent reaction for the syntheses of tetrahydro-spiro[pyrazolo[4,3-]quinoline]-8,5'-pyrimidines and tetrahydro-pyrazolo[4,3-]pyrimido[4,5-]quinolines selective multiple C-C bond formation under metal-free conditions.
一锅法合成具有抗癌活性的四氢嘧啶甲酰胺:与临床相关脑渗透药物的联合研究
RSC Adv. 2024 Aug 27;14(37):27174-27186. doi: 10.1039/d4ra04171b. eCollection 2024 Aug 22.
4
Development and optimisation of in vitro sonodynamic therapy for glioblastoma.体外声动力学疗法治疗脑胶质瘤的开发和优化。
Sci Rep. 2023 Nov 18;13(1):20215. doi: 10.1038/s41598-023-47562-2.
5
Pyrazolo[4,3-]tetrazolo[1,5-][1,2,4]triazine Sulfonamides as an Important Scaffold for Anticancer Drug Discovery-In Vitro and In Silico Evaluation.吡唑并[4,3-]四唑并[1,5-][1,2,4]三嗪磺酰胺类化合物作为抗癌药物发现的重要支架:体外和计算评估。
Int J Mol Sci. 2023 Jun 30;24(13):10959. doi: 10.3390/ijms241310959.
6
Dual inhibition of HSF1 and DYRK2 impedes cancer progression.双重抑制热休克转录因子 1 和双特异性酪氨酸磷酸化调节激酶 2 可阻碍癌症进展。
Biosci Rep. 2023 Jan 31;43(1). doi: 10.1042/BSR20222102.
7
Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells.香豆素衍生物的设计与合成及其对 HL60 和 HepG2 癌细胞中 PI3K/AKT 信号通路的抑制作用与细胞毒性。
Molecules. 2022 Oct 9;27(19):6709. doi: 10.3390/molecules27196709.
8
Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo.Syrbactin 类双重组成型和免疫蛋白酶体抑制剂 TIR-199 可抑制骨髓瘤体内介导的骨退化。
Biosci Rep. 2022 Feb 25;42(2). doi: 10.1042/BSR20212721.
一种用于合成四氢-螺[吡唑并[4,3 - ]喹啉]-8,5'-嘧啶和四氢-吡唑并[4,3 - ]嘧啶并[4,5 - ]喹啉的新型底物导向多组分反应,在无金属条件下选择性地形成多个C-C键。
RSC Adv. 2020 May 22;10(33):19600-19609. doi: 10.1039/d0ra02990d. eCollection 2020 May 20.
4
Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo.Syrbactin 类双重组成型和免疫蛋白酶体抑制剂 TIR-199 可抑制骨髓瘤体内介导的骨退化。
Biosci Rep. 2022 Feb 25;42(2). doi: 10.1042/BSR20212721.
5
Synthesis, DFT calculation, pharmacological evaluation, and catalytic application in the synthesis of diverse pyrano[2,3-c]pyrazole derivatives.合成、DFT 计算、药理学评价以及在合成多种吡喃并[2,3-c]吡唑衍生物中的催化应用。
Bioorg Chem. 2021 Sep;114:105136. doi: 10.1016/j.bioorg.2021.105136. Epub 2021 Jul 1.
6
Advances in Pyranopyrazole Scaffolds' Syntheses Using Sustainable Catalysts-A Review.可持续催化剂在吡喃并吡唑骨架合成中的应用进展综述。
Molecules. 2021 May 28;26(11):3270. doi: 10.3390/molecules26113270.
7
Kinase drug discovery 20 years after imatinib: progress and future directions.伊马替尼发现 20 年后的激酶药物研发:进展与未来方向
Nat Rev Drug Discov. 2021 Jul;20(7):551-569. doi: 10.1038/s41573-021-00195-4. Epub 2021 May 17.
8
The ABCs of the atypical Fam20 secretory pathway kinases.非典型 Fam20 分泌途径激酶的 ABCs
J Biol Chem. 2021 Jan-Jun;296:100267. doi: 10.1016/j.jbc.2021.100267. Epub 2021 Jan 8.
9
Protein kinase C fusion proteins are paradoxically loss of function in cancer.蛋白激酶 C 融合蛋白在癌症中表现出反常的功能丧失。
J Biol Chem. 2021 Jan-Jun;296:100445. doi: 10.1016/j.jbc.2021.100445. Epub 2021 Feb 20.
10
Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones.抗增殖苄氧基二氢嘧啶酮的合成及体外研究
Arch Pharm (Weinheim). 2021 Jun;354(6):e2000466. doi: 10.1002/ardp.202000466. Epub 2021 Feb 15.